Vasen H F, Lamers C B, Lips C J
Foundation for the Detection of Hereditary Tumors, Utrecht, the Netherlands.
Arch Intern Med. 1989 Dec;149(12):2717-22.
Since 1974, a total of 11 families with the multiple endocrine neoplasia syndrome type I (MEN-I), including 52 patients, were identified. Fifteen of these 52 patients died of MEN-I-related complications (mean age, 44 years), most of them in the period before screening was started. In 11 of the 15 patients, death was caused by complicated peptic ulcer disease, in 2 by metastasis of an endocrine pancreatic tumor, and in 2 by renal failure due to hyperparathyroidism. Family screening led to the diagnosis of 43 new endocrine lesions: 21 cases of hyperparathyroidism, 16 endocrine pancreatic tumors, and 6 pituitary tumors. Hyperparathyroidism either was the first manifestation of MEN-I or was diagnosed simultaneously with the other components of the syndrome in 44 (94%) of the 47 patients who underwent full evaluation.
自1974年以来,共识别出11个患有I型多发性内分泌腺瘤综合征(MEN-I)的家族,包括52名患者。这52名患者中有15名死于与MEN-I相关的并发症(平均年龄44岁),其中大多数死于筛查开始之前。在这15名患者中,11例死于复杂性消化性溃疡病,2例死于内分泌胰腺肿瘤转移,2例死于甲状旁腺功能亢进导致的肾衰竭。家族筛查导致诊断出43个新的内分泌病变:21例甲状旁腺功能亢进、16例内分泌胰腺肿瘤和6例垂体肿瘤。在接受全面评估的47例患者中,44例(94%)的甲状旁腺功能亢进要么是MEN-I的首发表现,要么是与该综合征的其他成分同时诊断出来的。